PHYTOMEDICAL TO EXPAND ITS RESEARCH ACTIVITIES TO INCLUDE NEW DRUG CANDIDATES
PhytoMedical Technologies, Inc., an early-stage research-based biopharmaceutical
company focused on the identification, development, and eventual commercialization
of innovative plant-derived pharmaceutical and nutraceutical compounds, today
announced its plans to actively pursue the research and development of additional
plant derived compounds targeting obesity, various types of cancer and Alzheimer's
disease, among others.